Point72 Hong Kong’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
ACA
VPC
Point72 Hong Kong's FOLD Position: Q3 2025 in Review
Point72 Hong Kong opened a new position in Amicus Therapeutics (FOLD) in Q3 2025: 13,524 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #349 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in FOLD as recently as Q1 2025.
Point72 Hong Kong first reported a position in FOLD in Q2 2018 and has held it in 15 quarters since. The position peaked at $170K in Q3 2021. 287 funds tracked by Wall St. Rank hold FOLD as of Q3 2025.
- Point72 Hong Kong held 13,524 shares of Amicus Therapeutics worth $107K as of Q3 2025.
- Amicus Therapeutics was a new Point72 Hong Kong position in Q3 2025.
- Amicus Therapeutics made up ﹤0.01% of Point72 Hong Kong's portfolio in Q3 2025, its #349 holding.
- Point72 Hong Kong first reported a position in Amicus Therapeutics in Q2 2018 and has held it in 15 quarters since.
- Point72 Hong Kong's Amicus Therapeutics position peaked at $170K in Q3 2021.
- 287 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2025.
Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.